Drug intelligence / Profile preview

Mai Luo Tong

Development stage
Unknown
Administration
Oral
01

Overview

Mai Luo Tong (脉络通) is a traditional Chinese medicine (TCM) or Chinese patent medicine primarily used for the treatment of cardiovascular and cerebrovascular diseases. It is generally indicated for conditions such as coronary heart disease with angina pectoris, hypertension, cerebrovascular accidents, and stroke-related symptoms like limb numbness and hemiplegia. Its therapeutic principles in TCM involve "unblocking meridians and collaterals, promoting qi circulation, and removing blood stasis." However, the exact composition of "Mai Luo Tong" can vary significantly between different manufacturers and formulations (e.g., tablets vs. capsules), with ingredients ranging from various herbs like Panax notoginseng, Salvia miltiorrhiza, and Angelica sinensis, to animal-derived components like Pheretima and artificial bezoar. It is classified as a pharmaceutical in China, evidenced by its "国药准字" (National Medical Product Administration approval number).

Brand names
Mai Luo Tong
Other names
脉络通
02

Targets

CX3CR1 (C-X3-C motif chemokine receptor 1)

Beyond the preview

Go deeper on Mai Luo Tong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mai Luo Tong.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call